| Year |
Citation |
Score |
| 2020 |
de Lima JM, Morand GB, Macedo CCS, Diesel L, Hier MP, Mlynarek A, Kowalski LP, Maschietto M, Alaoui-Jamali MA, Silva SDD. Ndrg1 Deficiency is associated with Regional Metastasis in Oral Cancer by inducing Epithelial-Mesenchymal transition. Carcinogenesis. PMID 32112078 DOI: 10.1093/Carcin/Bgaa017 |
0.407 |
|
| 2019 |
Sirois I, Aguilar-Mahecha A, Lafleur J, Fowler E, Vu V, Scriver M, Buchanan M, Chabot C, Ramanathan A, Balachandran B, Legare S, Przybytkowski E, Lan C, Krzemien U, Cavallone L, ... ... Alaoui-Jamali M, et al. A unique morphological phenotype in chemoresistant triple negative breast cancer reveals metabolic reprogramming and PLIN4 expression as a molecular vulnerability. Molecular Cancer Research : McR. PMID 31537618 DOI: 10.1158/1541-7786.Mcr-19-0264 |
0.36 |
|
| 2019 |
Shorstova T, Marques M, Su J, Johnston J, Kleinman CL, Hamel N, Huang S, Alaoui-Jamali MA, Foulkes WD, Witcher M. SWI/SNF-compromised cancers are susceptible to bromodomain inhibitors. Cancer Research. PMID 30877105 DOI: 10.1158/0008-5472.Can-18-1545 |
0.386 |
|
| 2019 |
Chang CH, Bijian K, Wernic D, Su J, da Silva SD, Yu H, Qiu D, Asslan M, Alaoui-Jamali MA. A novel orally available seleno-purine molecule suppresses triple-negative breast cancer cell proliferation and progression to metastasis by inducing cytostatic autophagy. Autophagy. PMID 30773992 DOI: 10.1080/15548627.2019.1582951 |
0.396 |
|
| 2019 |
Guo Q, Li VZ, Nichol JN, Huang F, Yang W, Preston SEJ, Talat Z, Lefrère H, Yu H, Zhang G, Basik M, Gonçalves C, Zhan Y, Plourde D, Su J, ... ... Alaoui-Jamali MA, et al. MNK1/NODAL signaling promotes invasive progression of breast ductal carcinoma in situ. Cancer Research. PMID 30659022 DOI: 10.1158/0008-5472.Can-18-1602 |
0.401 |
|
| 2018 |
Marques M, Jangal M, Wang LC, Kazanets A, da Silva SD, Zhao T, Lovato A, Yu H, Jie S, Del Rincon S, Mackey J, Damaraju S, Alaoui-Jamali M, Witcher M. Oncogenic activity of poly (ADP-ribose) glycohydrolase. Oncogene. PMID 30459355 DOI: 10.1038/S41388-018-0568-6 |
0.417 |
|
| 2018 |
Daniela da Silva S, Xu B, Maschietto M, Marchi FA, Alkailani MI, Bijian K, Xiao D, Alaoui-Jamali MA. TRAF2 COOPERATES WITH FOCAL ADHESION SIGNALING TO REGULATE CANCER CELL SUSCEPTIBILITY TO ANOIKIS. Molecular Cancer Therapeutics. PMID 30373932 DOI: 10.1158/1535-7163.Mct-17-1261 |
0.404 |
|
| 2018 |
Li L, Guturi KKN, Gautreau B, Patel PS, Saad A, Morii M, Mateo F, Palomero L, Barbour H, Gomez A, Ng D, Kotlyar M, Pastrello C, Jackson HW, Khokha R, ... ... Alaoui-Jamali M, et al. Ubiquitin ligase RNF8 suppresses Notch signaling to regulate mammary development and tumorigenesis. The Journal of Clinical Investigation. PMID 30222135 DOI: 10.1172/Jci120401 |
0.379 |
|
| 2018 |
Carnielli CM, Macedo CCS, De Rossi T, Granato DC, Rivera C, Domingues RR, Pauletti BA, Yokoo S, Heberle H, Busso-Lopes AF, Cervigne NK, Sawazaki-Calone I, Meirelles GV, Marchi FA, Telles GP, ... ... Alaoui-Jamali MA, et al. Combining discovery and targeted proteomics reveals a prognostic signature in oral cancer. Nature Communications. 9: 3598. PMID 30185791 DOI: 10.1038/S41467-018-05696-2 |
0.328 |
|
| 2018 |
Ghashghaei M, Muanza T, Alaoui-Jamali M, Paliouras M, Niazi MT. Abstract 858: Enzalutamide versus abiraterone as a radiosensitizer in hormone-sensitive prostate cancer cells Cancer Research. 78: 858-858. DOI: 10.1158/1538-7445.Am2018-858 |
0.379 |
|
| 2018 |
Soares Macedo CC, Rodrigues PC, Salo TA, Paes Leme AF, Alaoui-Jamali M, Da Silva SD, Coletta RD. Fascin-Dependent Invadopodia Formation in Oral Squamous Cell Carcinoma Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology. 126: e162. DOI: 10.1016/J.Oooo.2018.02.646 |
0.305 |
|
| 2017 |
Rodrigues PC, Sawazaki-Calone I, Ervolino de Oliveira C, Soares Macedo CC, Dourado MR, Cervigne NK, Miguel MC, Ferreira do Carmo A, Lambert DW, Graner E, Daniela da Silva S, Alaoui-Jamali MA, Paes Leme AF, Salo TA, Coletta RD. Fascin promotes migration and invasion and is a prognostic marker for oral squamous cell carcinoma. Oncotarget. 8: 74736-74754. PMID 29088820 DOI: 10.18632/Oncotarget.20360 |
0.376 |
|
| 2017 |
Zhan Y, Guo J, Yang W, Goncalves C, Rzymski T, Dreas A, Żyłkiewicz E, Mikulski M, Brzózka K, Golas A, Kong Y, Ma M, Huang F, Huor B, Guo Q, ... ... Alaoui-Jamali MA, et al. MNK1/2 inhibition limits oncogenicity and metastasis of KIT-mutant melanoma. The Journal of Clinical Investigation. PMID 29035277 DOI: 10.1172/Jci91258 |
0.368 |
|
| 2017 |
Bijian K, Kaldre D, Wang TT, Bouttier M, Boucher A, Alaoui-Jamali M, White JH, Gleason JL. Efficacy of Hybrid Vitamin D Receptor Agonist/Histone Deacetylase Inhibitors in Vitamin D-Resistant Triple-Negative 4T1 Breast Cancer. The Journal of Steroid Biochemistry and Molecular Biology. PMID 28847749 DOI: 10.1016/J.Jsbmb.2017.08.010 |
0.327 |
|
| 2017 |
Hilmi K, Jangal M, Marques M, Zhao T, Saad A, Zhang C, Luo VM, Syme A, Rejon C, Yu Z, Krum A, Fabian MR, Richard S, Alaoui-Jamali M, Orthwein A, et al. CTCF facilitates DNA double-strand break repair by enhancing homologous recombination repair. Science Advances. 3: e1601898. PMID 28560323 DOI: 10.1126/Sciadv.1601898 |
0.348 |
|
| 2017 |
Chang CH, Bijian K, Qiu D, Su J, Saad A, Dahabieh MS, Miller WH, Alaoui-Jamali MA. Endosomal sorting and c-Cbl targeting of paxillin to autophagosomes regulate cell-matrix adhesion turnover in human breast cancer cells. Oncotarget. PMID 28415719 DOI: 10.18632/Oncotarget.16105 |
0.394 |
|
| 2017 |
Hilmi K, Zhang C, Yu Z, Saad A, Richard S, McCaffrey L, Alaoui-Jamali MA, Witcher M. Abstract A12: CTCF facilitates DNA double-strand break repair by homologous recombination Molecular Cancer Research. 15. DOI: 10.1158/1557-3125.Dnarepair16-A12 |
0.362 |
|
| 2016 |
Kahouli I, Malhotra M, Westfall S, Alaoui-Jamali MA, Prakash S. Design and validation of an orally administrated active L. fermentum-L. acidophilus probiotic formulation using colorectal cancer Apc (Min/+) mouse model. Applied Microbiology and Biotechnology. PMID 27837314 DOI: 10.1007/S00253-016-7885-X |
0.373 |
|
| 2016 |
Nassour H, Wang Z, Saad A, Papaluca A, Brosseau N, Affar EB, Alaoui-Jamali MA, Ramotar D. Peroxiredoxin 1 interacts with and blocks the redox factor APE1 from activating interleukin-8 expression. Scientific Reports. 6: 29389. PMID 27388124 DOI: 10.1038/Srep29389 |
0.376 |
|
| 2016 |
Bakkar A, Alshalalfa M, Petersen LF, Abou-Ouf H, Al-Mami A, Hegazy SA, Feng F, Alhajj R, Bijian K, Alaoui-Jamali MA, Bismar TA. microRNA 338-3p exhibits tumor suppressor role and its down-regulation is associated with adverse clinical outcome in prostate cancer patients. Molecular Biology Reports. PMID 26907180 DOI: 10.1007/S11033-016-3948-4 |
0.321 |
|
| 2015 |
da Silva SD, Marchi FA, Xu B, Bijian K, Alobaid F, Mlynarek A, Rogatto SR, Hier M, Kowalski LP, Alaoui-Jamali MA. Predominant Rab-GTPase amplicons contributing to oral squamous cell carcinoma progression to metastasis. Oncotarget. PMID 26110570 DOI: 10.18632/Oncotarget.4277 |
0.399 |
|
| 2015 |
Alaoui-Jamali MA, Morand GB, da Silva SD. ErbB polymorphisms: insights and implications for response to targeted cancer therapeutics. Frontiers in Genetics. 6: 17. PMID 25699077 DOI: 10.3389/Fgene.2015.00017 |
0.323 |
|
| 2015 |
Peña-Hernández R, Marques M, Hilmi K, Zhao T, Saad A, Alaoui-Jamali MA, del Rincon SV, Ashworth T, Roy AL, Emerson BM, Witcher M. Genome-wide targeting of the epigenetic regulatory protein CTCF to gene promoters by the transcription factor TFII-I. Proceedings of the National Academy of Sciences of the United States of America. 112: E677-86. PMID 25646466 DOI: 10.1073/Pnas.1416674112 |
0.309 |
|
| 2015 |
da Silva SD, Morand GB, Alobaid FA, Hier MP, Mlynarek AM, Alaoui-Jamali MA, Kowalski LP. Epithelial-mesenchymal transition (EMT) markers have prognostic impact in multiple primary oral squamous cell carcinoma. Clinical & Experimental Metastasis. 32: 55-63. PMID 25433796 DOI: 10.1007/S10585-014-9690-1 |
0.337 |
|
| 2014 |
Xiao D, Chen S, Shao Q, Chen J, Bijian K, Laird DW, Alaoui-Jamali MA. Dynamin 2 interacts with connexin 26 to regulate its degradation and function in gap junction formation. The International Journal of Biochemistry & Cell Biology. 55: 288-97. PMID 25263585 DOI: 10.1016/J.Biocel.2014.09.021 |
0.318 |
|
| 2014 |
Xu B, Teng LH, Silva SD, Bijian K, Al Bashir S, Jie S, Dolph M, Alaoui-Jamali MA, Bismar TA. The significance of dynamin 2 expression for prostate cancer progression, prognostication, and therapeutic targeting. Cancer Medicine. 3: 14-24. PMID 24402972 DOI: 10.1002/Cam4.168 |
0.378 |
|
| 2014 |
da Silva SD, Alaoui-Jamali MA, Soares FA, Carraro DM, Brentani HP, Hier M, Rogatto SR, Kowalski LP. TWIST1 is a molecular marker for a poor prognosis in oral cancer and represents a potential therapeutic target. Cancer. 120: 352-62. PMID 24150986 DOI: 10.1002/Cncr.28404 |
0.317 |
|
| 2013 |
Bijian K, Lougheed C, Su J, Xu B, Yu H, Wu JH, Riccio K, Alaoui-Jamali MA. Targeting focal adhesion turnover in invasive breast cancer cells by the purine derivative reversine British Journal of Cancer. 109: 2810-2818. PMID 24169345 DOI: 10.1038/Bjc.2013.675 |
0.369 |
|
| 2013 |
Garcia AG, Nedev H, Bijian K, Su J, Alaoui-Jamali MA, Saragovi HU. Reduced in vivo lung metastasis of a breast cancer cell line after treatment with Herceptin mAb conjugated to chemotherapeutic drugs. Oncogene. 32: 2527-33. PMID 22797066 DOI: 10.1038/Onc.2012.283 |
0.334 |
|
| 2013 |
Silva SD, Alaoui-Jamali MA, Soares FA, Hier M, Rogatto SR, Kowalski LP. PP077 Oral Oncology. 49: S120. DOI: 10.1016/J.Oraloncology.2013.03.320 |
0.389 |
|
| 2013 |
Silva SD, Alobaid FA, Alaoui-Jamali M, Hier MP, Mlynarek A, Soares FA, Kowalski LP. PP022 Oral Oncology. 49: S101. DOI: 10.1016/J.Oraloncology.2013.03.265 |
0.319 |
|
| 2012 |
da Silva SD, Hier M, Mlynarek A, Kowalski LP, Alaoui-Jamali MA. Recurrent oral cancer: current and emerging therapeutic approaches. Frontiers in Pharmacology. 3: 149. PMID 23060791 DOI: 10.3389/Fphar.2012.00149 |
0.307 |
|
| 2012 |
Valentin MD, da Silva SD, Privat M, Alaoui-Jamali M, Bignon YJ. Molecular insights on basal-like breast cancer. Breast Cancer Research and Treatment. 134: 21-30. PMID 22234518 DOI: 10.1007/S10549-011-1934-Z |
0.32 |
|
| 2012 |
Bijian K, Zhang Z, Xu B, Jie S, Chen B, Wan S, Wu J, Jiang T, Alaoui-Jamali MA. Synthesis and biological activity of novel organoselenium derivatives targeting multiple kinases and capable of inhibiting cancer progression to metastases. European Journal of Medicinal Chemistry. 48: 143-52. PMID 22204902 DOI: 10.1016/J.Ejmech.2011.12.006 |
0.389 |
|
| 2011 |
Zhang P, Sun X, Xu B, Bijian K, Wan S, Li G, Alaoui-Jamali M, Jiang T. Total synthesis and bioactivity of the marine alkaloid pityriacitrin and some of its derivatives. European Journal of Medicinal Chemistry. 46: 6089-97. PMID 22047643 DOI: 10.1016/J.Ejmech.2011.10.036 |
0.339 |
|
| 2010 |
Xu Y, Bismar TA, Su J, Xu B, Kristiansen G, Varga Z, Teng L, Ingber DE, Mammoto A, Kumar R, Alaoui-Jamali MA. Filamin A regulates focal adhesion disassembly and suppresses breast cancer cell migration and invasion. The Journal of Experimental Medicine. 207: 2421-37. PMID 20937704 DOI: 10.1084/Jem.20100433 |
0.379 |
|
| 2009 |
Alaoui-Jamali MA, Gupta A, Szarek WA, Bismar TA, Gheorghe R, Schipper HM. A novel selective therapeutic targeting heme oxygenase-1 revealed a potent antimetastatic activity in androgen-refractory human prostate cancer models. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: e16090. PMID 27963085 DOI: 10.1200/Jco.2009.27.15_Suppl.E16090 |
0.38 |
|
| 2009 |
Alaoui-Jamali MA, Bismar TA, Gupta A, Szarek WA, Su J, Song W, Xu Y, Xu B, Liu G, Vlahakis JZ, Roman G, Jiao J, Schipper HM. A novel experimental heme oxygenase-1-targeted therapy for hormone-refractory prostate cancer. Cancer Research. 69: 8017-24. PMID 19808972 DOI: 10.1158/0008-5472.Can-09-0419 |
0.414 |
|
| 2009 |
Bijian K, Mlynarek AM, Balys RL, Jie S, Xu Y, Hier MP, Black MJ, Di Falco MR, LaBoissiere S, Alaoui-Jamali MA. Serum proteomic approach for the identification of serum biomarkers contributed by oral squamous cell carcinoma and host tissue microenvironment. Journal of Proteome Research. 8: 2173-85. PMID 19284786 DOI: 10.1021/Pr800979E |
0.361 |
|
| 2009 |
Poondra RR, Kumar NN, Bijian K, Prakesch M, Campagna-Slater V, Reayi A, Reddy PT, Choudhry A, Barnes ML, Leek DM, Daroszewska M, Lougheed C, Xu B, Schapira M, Alaoui-Jamali MA, et al. Discovery of indoline-based, natural-product-like compounds as probes of focal adhesion kinase signaling pathways. Journal of Combinatorial Chemistry. 11: 303-9. PMID 19146410 DOI: 10.1021/Cc8001525 |
0.304 |
|
| 2008 |
Behmoaram E, Bijian K, Jie S, Xu Y, Darnel A, Bismar TA, Alaoui-Jamali MA. Focal adhesion kinase-related proline-rich tyrosine kinase 2 and focal adhesion kinase are co-overexpressed in early-stage and invasive ErbB-2-positive breast cancer and cooperate for breast cancer cell tumorigenesis and invasiveness. The American Journal of Pathology. 173: 1540-50. PMID 18832579 DOI: 10.2353/Ajpath.2008.080292 |
0.378 |
|
| 2008 |
Behmoaram E, Bijian K, Bismar TA, Alaoui-Jamali MA. Early stage cancer cell invasion: signaling, biomarkers and therapeutic targeting. Frontiers in Bioscience : a Journal and Virtual Library. 13: 6314-25. PMID 18508662 DOI: 10.2741/3156 |
0.368 |
|
| 2007 |
Mlynarek AM, Balys RL, Su J, Hier MP, Black MJ, Alaoui-Jamali MA. A cell proteomic approach for the detection of secretable biomarkers of invasiveness in oral squamous cell carcinoma. Archives of Otolaryngology--Head & Neck Surgery. 133: 910-8. PMID 17875858 DOI: 10.1001/Archotol.133.9.910 |
0.401 |
|
| 2007 |
Li B, Lyle MP, Chen G, Li J, Hu K, Tang L, Alaoui-Jamali MA, Webster J. Substituted 6-amino-4H-[1,2]dithiolo[4,3-b]pyrrol-5-ones: synthesis, structure-activity relationships, and cytotoxic activity on selected human cancer cell lines. Bioorganic & Medicinal Chemistry. 15: 4601-8. PMID 17467996 DOI: 10.1016/J.Bmc.2007.04.017 |
0.337 |
|
| 2007 |
Darwish H, Cho JM, Loignon M, Alaoui-Jamali MA. Overexpression of SERTAD3, a putative oncogene located within the 19q13 amplicon, induces E2F activity and promotes tumor growth Oncogene. 26: 4319-4328. PMID 17260023 DOI: 10.1038/Sj.Onc.1210195 |
0.365 |
|
| 2006 |
Alaoui-Jamali MA. Protein tyrosine kinase signaling diversity and susceptibility to targeted kinase inhibitors Biomedicine and Pharmacotherapy. 60: 629-632. PMID 16949787 DOI: 10.1016/J.Biopha.2006.08.003 |
0.308 |
|
| 2006 |
Kalra J, Shao Q, Qin H, Thomas T, Alaoui-Jamali MA, Laird DW. Cx26 inhibits breast MDA-MB-435 cell tumorigenic properties by a gap junctional intercellular communication-independent mechanism. Carcinogenesis. 27: 2528-37. PMID 16777986 DOI: 10.1093/Carcin/Bgl110 |
0.42 |
|
| 2006 |
Hernandez M, Shao Q, Yang XJ, Luh SP, Kandouz M, Batist G, Laird DW, Alaoui-Jamali MA. A histone deacetylation-dependent mechanism for transcriptional repression of the gap junction gene cx43 in prostate cancer cells. The Prostate. 66: 1151-61. PMID 16652385 DOI: 10.1002/Pros.20451 |
0.33 |
|
| 2006 |
Alaoui-Jamali MA, Xu YJ. Proteomic technology for biomarker profiling in cancer: an update. Journal of Zhejiang University. Science. B. 7: 411-20. PMID 16625706 DOI: 10.1631/Jzus.2006.B0411 |
0.321 |
|
| 2006 |
Mlynarek AM, Balys R, Jie S, Xu Y, Hier MP, Black MJ, Alaoui-Jamali MA. A concerted cell and serum proteomic approach for the identification of oral squamous cell carcinoma biomarkers Journal of Clinical Oncology. 24: 5512-5512. DOI: 10.1200/Jco.2006.24.18_Suppl.5512 |
0.395 |
|
| 2006 |
Mlynarek AM, Balys RL, Hier MP, Black MJ, Alaoui-Jamali MA. S025 Biomarkers of Invasiveness in Oral Squamous Cell Carcinoma: A Cell Proteomic Approach Archives of Otolaryngology–Head & Neck Surgery. 132: 844. DOI: 10.1001/Archotol.132.8.844-A |
0.331 |
|
| 2005 |
Benlimame N, He Q, Jie S, Xiao D, Xu YJ, Loignon M, Schlaepfer DD, Alaoui-Jamali MA. FAK signaling is critical for ErbB-2/ErbB-3 receptor cooperation for oncogenic transformation and invasion. The Journal of Cell Biology. 171: 505-16. PMID 16275754 DOI: 10.1083/Jcb.200504124 |
0.369 |
|
| 2005 |
Brahimi F, Rachid Z, McNamee JP, Alaoui-Jamali MA, Tari AM, Jean-Claude BJ. Mechanism of action of a novel "combi-triazene" engineered to possess a polar functional group on the alkylating moiety: evidence for enhancement of potency. Biochemical Pharmacology. 70: 511-9. PMID 15982640 DOI: 10.1016/J.Bcp.2005.04.037 |
0.369 |
|
| 2005 |
Mamane Y, Loignon M, Palmer J, Hernandez E, Césaire R, Alaoui-Jamali M, Hiscott J. Repression of DNA repair mechanisms in IRF-4-expressing and HTLV-I-infected T lymphocytes. Journal of Interferon & Cytokine Research : the Official Journal of the International Society For Interferon and Cytokine Research. 25: 43-51. PMID 15684621 DOI: 10.1089/Jir.2005.25.43 |
0.352 |
|
| 2004 |
Alaoui-Jamali MA, Dupré I, Qiang H. Prediction of drug sensitivity and drug resistance in cancer by transcriptional and proteomic profiling. Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy. 7: 245-55. PMID 15533762 DOI: 10.1016/J.Drup.2004.06.004 |
0.325 |
|
| 2004 |
Mathonnet G, Lachance S, Alaoui-Jamali M, Drobetsky EA. Expression of hepatitis B virus X oncoprotein inhibits transcription-coupled nucleotide excision repair in human cells. Mutation Research. 554: 305-18. PMID 15450428 DOI: 10.1016/J.Mrfmmm.2004.05.010 |
0.405 |
|
| 2004 |
Matheson SL, McNamee JP, Wang T, Alaoui-Jamali MA, Tari AM, Jean-Claude BJ. The combi-targeting concept: dissection of the binary mechanism of action of the combi-triazene SMA41 in vitro and antitumor activity in vivo. The Journal of Pharmacology and Experimental Therapeutics. 311: 1163-70. PMID 15358812 DOI: 10.1124/Jpet.104.071977 |
0.379 |
|
| 2004 |
Chow TY, Alaoui-Jamali MA, Yeh C, Yuen L, Griller D. The DNA double-stranded break repair protein endo-exonuclease as a therapeutic target for cancer. Molecular Cancer Therapeutics. 3: 911-9. PMID 15299074 |
0.336 |
|
| 2004 |
Kandouz M, Bier A, Carystinos GD, Alaoui-Jamali MA, Batist G. Connexin43 pseudogene is expressed in tumor cells and inhibits growth. Oncogene. 23: 4763-70. PMID 15122329 DOI: 10.1038/Sj.Onc.1207506 |
0.435 |
|
| 2004 |
Al Moustafa AE, Foulkes WD, Benlimame N, Wong A, Yen L, Bergeron J, Batist G, Alpert L, Alaoui-Jamali MA. E6/E7 proteins of HPV type 16 and ErbB-2 cooperate to induce neoplastic transformation of primary normal oral epithelial cells. Oncogene. 23: 350-8. PMID 14724563 DOI: 10.1038/Sj.Onc.1207148 |
0.318 |
|
| 2003 |
Qin H, Shao Q, Thomas T, Kalra J, Alaoui-Jamali MA, Laird DW. Connexin26 regulates the expression of angiogenesis-related genes in human breast tumor cells by both GJIC-dependent and -independent mechanisms. Cell Communication & Adhesion. 10: 387-93. PMID 14681046 DOI: 10.1080/Cac.10.4-6.387.393 |
0.392 |
|
| 2003 |
Qin H, Shao Q, Igdoura SA, Alaoui-Jamali MA, Laird DW. Lysosomal and proteasomal degradation play distinct roles in the life cycle of Cx43 in gap junctional intercellular communication-deficient and -competent breast tumor cells. The Journal of Biological Chemistry. 278: 30005-14. PMID 12767974 DOI: 10.1074/Jbc.M300614200 |
0.379 |
|
| 2003 |
Alaoui-Jamali MA, Qiang H. The interface between ErbB and non-ErbB receptors in tumor invasion: clinical implications and opportunities for target discovery. Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy. 6: 95-107. PMID 12729807 DOI: 10.1016/S1368-7646(03)00024-4 |
0.337 |
|
| 2003 |
Carystinos GD, Kandouz M, Alaoui-Jamali MA, Batist G. Unexpected induction of the human connexin 43 promoter by the ras signaling pathway is mediated by a novel putative promoter sequence. Molecular Pharmacology. 63: 821-31. PMID 12644583 DOI: 10.1124/Mol.63.4.821 |
0.344 |
|
| 2002 |
Yen L, Benlimame N, Nie ZR, Xiao D, Wang T, Al Moustafa AE, Esumi H, Milanini J, Hynes NE, Pages G, Alaoui-Jamali MA. Differential regulation of tumor angiogenesis by distinct ErbB homo- and heterodimers. Molecular Biology of the Cell. 13: 4029-44. PMID 12429844 DOI: 10.1091/Mbc.E02-02-0084 |
0.336 |
|
| 2002 |
Al Moustafa AE, Yen L, Benlimame N, Alaoui-Jamali MA. Regulation of E-cadherin/catenin complex patterns by epidermal growth factor receptor modulation in human lung cancer cells. Lung Cancer (Amsterdam, Netherlands). 37: 49-56. PMID 12057867 DOI: 10.1016/S0169-5002(02)00025-9 |
0.361 |
|
| 2002 |
Xu Z, Chen ZP, Malapetsa A, Alaoui-Jamali M, Bergeron J, Monks A, Myers TG, Mohr G, Sausville EA, Scudiero DA, Aloyz R, Panasci LC. DNA repair protein levels vis-à-vis anticancer drug resistance in the human tumor cell lines of the National Cancer Institute drug screening program. Anti-Cancer Drugs. 13: 511-9. PMID 12045463 DOI: 10.1097/00001813-200206000-00010 |
0.419 |
|
| 2002 |
Qin H, Shao Q, Curtis H, Galipeau J, Belliveau DJ, Wang T, Alaoui-Jamali MA, Laird DW. Retroviral delivery of connexin genes to human breast tumor cells inhibits in vivo tumor growth by a mechanism that is independent of significant gap junctional intercellular communication. The Journal of Biological Chemistry. 277: 29132-8. PMID 12042301 DOI: 10.1074/Jbc.M200797200 |
0.376 |
|
| 2002 |
Barsalou A, Dayan G, Anghel SI, Alaoui-Jamali M, Van de Velde P, Mader S. Growth-stimulatory and transcriptional activation properties of raloxifene in human endometrial Ishikawa cells. Molecular and Cellular Endocrinology. 190: 65-73. PMID 11997179 DOI: 10.1016/S0303-7207(02)00011-4 |
0.361 |
|
| 2002 |
Al Moustafa AE, Alaoui-Jamali MA, Batist G, Hernandez-Perez M, Serruya C, Alpert L, Black MJ, Sladek R, Foulkes WD. Identification of genes associated with head and neck carcinogenesis by cDNA microarray comparison between matched primary normal epithelial and squamous carcinoma cells. Oncogene. 21: 2634-40. PMID 11965536 DOI: 10.1038/Sj.Onc.1205351 |
0.39 |
|
| 2001 |
Huynh H, Alpert L, Alaoui-Jamali MA, Ng CY, Chan TWM. Co-administration of finasteride and the pure anti-oestrogen ICI 182,780 act synergistically in modulating the IGF system in rat prostate Journal of Endocrinology. 171: 109-118. PMID 11572795 DOI: 10.1677/Joe.0.1710109 |
0.325 |
|
| 2001 |
Trudeau C, Yuan S, Galipeau J, Benlimame N, Alaoui-Jamali MA, Batist G. A novel parasite-derived suicide gene for cancer gene therapy with specificity for lung cancer cells Human Gene Therapy. 12: 1673-1680. PMID 11535170 DOI: 10.1089/10430340152528165 |
0.388 |
|
| 2001 |
Marcantonio D, Chalifour LE, Alaoui-Jamali And H T Huynh MA, Alaoui-Jamali MA, Alaoui-Jamali MA, Huynh HT, Huynh HT. Steroid-sensitive gene-1 is an androgen-regulated gene expressed in prostatic smooth muscle cells in vivo. Journal of Molecular Endocrinology. 26: 175-84. PMID 11357054 DOI: 10.1677/Jme.0.0260175 |
0.684 |
|
| 2001 |
Marcantonio D, Chalifour LE, Alaoui-Jamali MA, Alpert L, Huynh HT. Cloning and characterization of a novel gene that is regulated by estrogen and is associated with mammary gland carcinogenesis. Endocrinology. 142: 2409-18. PMID 11356689 DOI: 10.1210/Endo.142.6.8154 |
0.699 |
|
| 2001 |
Prudencio J, Akutsu N, Benlimame N, Wang T, Bastien Y, Lin R, Black MJ, Alaoui-Jamali MA, White JH. Action of low calcemic 1α,25-dihydroxyvitamin D3 analogue EB1089 in head and neck squamous cell carcinoma Journal of the National Cancer Institute. 93: 745-753. PMID 11353784 DOI: 10.1093/Jnci/93.10.745 |
0.374 |
|
| 2001 |
Jaitovich-Groisman I, Benlimame N, Slagle BL, Perez MH, Alpert L, Song DJ, Fotouhi-Ardakani N, Galipeau J, Alaoui-Jamali MA. Transcriptional Regulation of the TFIIH Transcription Repair Components XPB and XPD by the Hepatitis B Virus x Protein in Liver Cells and Transgenic Liver Tissue Journal of Biological Chemistry. 276: 14124-14132. PMID 11278765 DOI: 10.1074/Jbc.M010852200 |
0.4 |
|
| 2001 |
Carystinos GD, Alaoui-Jamali MA, Phipps J, Yen L, Batist G. Upregulation of gap junctional intercellular communication and connexin 43 expression by cyclic-AMP and all-trans-retinoic acid is associated with glutathione depletion and chemosensitivity in neuroblastoma cells Cancer Chemotherapy and Pharmacology. 47: 126-132. PMID 11269738 DOI: 10.1007/S002800000231 |
0.362 |
|
| 2001 |
Caruso JA, Reiners JJ, Emond J, Shultz T, Tainsky MA, Alaoui-Jamali M, Batist G. Genetic alteration of chromosome 8 is a common feature of human mammary epithelial cell lines transformed in vitro with benzo[a]pyrene. Mutation Research. 473: 85-99. PMID 11166028 DOI: 10.1016/S0027-5107(00)00140-8 |
0.34 |
|
| 2000 |
Cho JM, Song DJ, Bergeron J, Benlimame N, Wold MS, Alaoui-Jamali MA. RBT1, a novel transcriptional co-activator, binds the second subunit of replication protein A. Nucleic Acids Research. 28: 3478-85. PMID 10982866 DOI: 10.1093/Nar/28.18.3478 |
0.426 |
|
| 2000 |
Jaitovitch-Groisman I, Fotouhi-Ardakani N, Schecter RL, Woo A, Alaoui-Jamali MA, Batist G. Modulation of glutathione S-transferase alpha by hepatitis B virus and the chemopreventive drug oltipraz Journal of Biological Chemistry. 275: 33395-33403. PMID 10934196 DOI: 10.1074/Jbc.M003754200 |
0.37 |
|
| 2000 |
Yen L, You XL, Al Moustafa AE, Batist G, Hynes NE, Mader S, Meloche S, Alaoui-Jamali MA. Heregulin selectively upregulates vascular endothelial growth factor secretion in cancer cells and stimulates angiogenesis Oncogene. 19: 3460-3469. PMID 10918604 DOI: 10.1038/Sj.Onc.1203685 |
0.375 |
|
| 2000 |
Sohn S, Jaitovitch-Groisman I, Benlimame N, Galipeau J, Batist G, Alaoui-Jamali MA. Retroviral expression of the hepatitis B virus x gene promotes liver cell susceptibility to carcinogen-induced site specific mutagenesis Mutation Research - Dna Repair. 460: 17-28. PMID 10856831 DOI: 10.1016/S0921-8777(00)00010-0 |
0.392 |
|
| 1999 |
Horton JK, Roy G, Piper JT, Van Houten B, Awasthi YC, Mitra S, Alaoui-Jamali MA, Boldogh I, Singhal SS. Characterization of a chlorambucil-resistant human ovarian carcinoma cell line overexpressing glutathione S-transferase μ Biochemical Pharmacology. 58: 693-702. PMID 10413308 DOI: 10.1016/S0006-2952(99)00142-2 |
0.341 |
|
| 1999 |
Groisman IJ, Koshy R, Henkler F, Groopman JD, Alaoui-Jamali MA. Downregulation of DNA excision repair by the hepatitis B virus-x protein occurs in p53-proficient and p53-deficient cells. Carcinogenesis. 20: 479-83. PMID 10190565 DOI: 10.1093/Carcin/20.3.479 |
0.708 |
|
| 1998 |
Arya P, Alibhai N, Qin H, Burton GW, Batist G, You SXL, Alaoui-Jamali MA. Design and synthesis of analogs of vitamin E: Antiproliferative activity against human breast adenocarcinoma cells Bioorganic and Medicinal Chemistry Letters. 8: 2433-2438. PMID 9873556 DOI: 10.1016/S0960-894X(98)00438-7 |
0.313 |
|
| 1998 |
You XL, Yen L, Zeng-Rong N, Al Moustafa AE, Alaoui-Jamali MA. Dual effect of erbB-2 depletion on the regulation of DNA repair and cell cycle mechanisms in non-small cell lung cancer cells Oncogene. 17: 3177-3186. PMID 9872333 DOI: 10.1038/Sj.Onc.1202246 |
0.451 |
|
| 1998 |
Paterson J, Uriel C, Egron MJ, Herscovici J, Antonakis K, Alaoui-Jamali MA. Antiproliferative and apoptotic activities of ketonucleosides and keto- C-glycosides against non-small-cell lung cancer cells with intrinsic drug resistance Antimicrobial Agents and Chemotherapy. 42: 779-784. PMID 9559782 DOI: 10.1128/Aac.42.4.779 |
0.384 |
|
| 1998 |
Christodoulopoulos G, Fotouhi N, Krajewski S, Reed JC, Alaoui-Jamali M, Panasci L. Relationship between nitrogen mustard drug resistance in B-cell chronic lymphocytic leukemia (B-CLL) and protein expression of Bcl-2, Bax, Bcl-X and p53. Cancer Letters. 121: 59-67. PMID 9459175 DOI: 10.1016/S0304-3835(97)00336-4 |
0.316 |
|
| 1997 |
Alaoui-Jamali MA, Paterson J, Al Moustafa AE, Yen L. The role of ErbB-2 tyrosine kinase receptor in cellular intrinsic chemoresistance: Mechanisms and implications Biochemistry and Cell Biology. 75: 315-325. PMID 9493954 DOI: 10.1139/O97-060 |
0.42 |
|
| 1997 |
Yen L, Zeng-Rong N, You XL, Richard S, Langton-Webster BC, Alaoui-Jamali MA. Regulation of cellular response to cisplatin-induced DNA damage and DNA repair in cells overexpressing p185(erbB-2) is dependent on the ras signaling pathway Oncogene. 14: 1827-1835. PMID 9150389 DOI: 10.1038/Sj.Onc.1201019 |
0.384 |
|
| 1995 |
Yen L, Woo A, Christopoulopoulos G, Batist G, Panasci L, Roy R, Mitra S, Alaoui-Jamali MA. Enhanced host cell reactivation capacity and expression of DNA repair genes in human breast cancer cells resistant to bi-functional alkylating agents Mutation Research-Dna Repair. 337: 179-189. PMID 7491121 DOI: 10.1016/0921-8777(95)00022-C |
0.441 |
|
| 1994 |
Alaoui-Jamali M, Loubaba BB, Robyn S, Tapiero H, Batist G. Effect of DNA-repair-enzyme modulators on cytotoxicity of L-phenylalanine mustard and cis-diamminedichloroplatinum (II) in mammary carcinoma cells resistant to alkylating drugs. Cancer Chemotherapy and Pharmacology. 34: 153-8. PMID 8194166 DOI: 10.1007/Bf00685933 |
0.36 |
|
| 1994 |
C.-Gaudreault R, Alaoui-Jamali MA, Batist G, Béchard P, Lacroix J, Poyet P. Lack of cross-resistance to a new cytotoxic arylchloroethyl urea in various drug-resistant tumor cells Cancer Chemotherapy and Pharmacology. 33: 489-492. PMID 8137459 DOI: 10.1007/Bf00686506 |
0.349 |
|
| 1993 |
Schecter RL, Alaoui-Jamali MA, Woo A, Fahl WE, Batist G. Expression of a rat glutathione-S-transferase complementary DNA in rat mammary carcinoma cells: impact upon alkylator-induced toxicity. Cancer Research. 53: 4900-6. PMID 8402679 |
0.335 |
|
| 1992 |
Alaoui-Jamali MA, Batist G, Lehnert S. Radiation-induced damage to DNA in drug- and radiation-resistant sublines of a human breast cancer cell line Radiation Research. 129: 37-42. PMID 1728055 DOI: 10.2307/3577900 |
0.354 |
|
| 1992 |
Alaoui-Jamali MA, Panasci L, Centurioni GM, Schecter R, Lehnert S, Batist G. Nitrogen mustard-DNA interaction in melphalan-resistant mammary carcinoma cells with elevated intracellular glutathione and glutathione-S-transferase activity Cancer Chemotherapy and Pharmacology. 30: 341-347. PMID 1505071 DOI: 10.1007/Bf00689960 |
0.402 |
|
| 1992 |
Schecter RL, Alaoui-Jamali MA, Batist G. Glutathione S-transferase in chemotherapy resistance and in carcinogenesis Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire. 70: 349-353. PMID 1353967 DOI: 10.1139/O92-054 |
0.334 |
|
| 1987 |
Alaoui-Jamali MA, Egron MJ, Bessodes M, Antonakis K, Chouroulinkov I. Relationship between the structure and cytotoxic activity of new unsaturated ketonucleosides tested on eight cell lines European Journal of Medicinal Chemistry. 22: 305-310. DOI: 10.1016/0223-5234(87)90267-4 |
0.325 |
|
| Show low-probability matches. |